Close

Cowen Starts Sage Therapeutics (SAGE) at Outperform

May 28, 2015 6:15 AM EDT Send to a Friend
Cowen initiates coverage on Sage Therapeutics (NASDAQ: SAGE) with a Outperform rating and a price target of $95.00.Analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login